roclanda
santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - augnlækningar - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.
latanoprost actavis augndropar, lausn 50 míkróg/ml
actavis group ptc ehf. - latanoprostum inn - augndropar, lausn - 50 míkróg/ml
lextemy
mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - Æxlishemjandi lyf - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.
cipralex filmuhúðuð tafla 5 mg
h. lundbeck a/s* - escitalopram oxalate - filmuhúðuð tafla - 5 mg
cipralex filmuhúðuð tafla 20 mg
h. lundbeck a/s* - escitalopram oxalate - filmuhúðuð tafla - 20 mg
cipralex filmuhúðuð tafla 15 mg
h. lundbeck a/s* - escitalopram oxalate - filmuhúðuð tafla - 15 mg
cipralex filmuhúðuð tafla 10 mg
h. lundbeck a/s* - escitalopram oxalate - filmuhúðuð tafla - 10 mg
octaplex innrennslisstofn og leysir, lausn 1000 a.e.
octapharma ab - factor ii human; factor vii human; factor ix human; factor x human; protein c; protein s - innrennslisstofn og leysir, lausn - 1000 a.e.
octaplex innrennslisstofn og leysir, lausn 500 a.e.
octapharma ab - factor ii human; factor vii human; factor ix human; factor x human; protein c; protein s - innrennslisstofn og leysir, lausn - 500 a.e.
enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - Ónæmisbælandi lyf - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).